Error: Could not add to watchlist. X

Harel 4B Selected Biomed

+ Watchlist
IL30EQY:IT
Price not available for IL30EQY:IT
ILs
Fund Type
Open-End Fund
52Wk Range
2,540.33 - 3,491.06
Previous Close
2,825.14
52Wk Range
2,540.33 - 3,491.06
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on -)
-
Total Assets (m ILS) (on 06/30/2015)
16.200
Inception Date
01/01/1993
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
-
Front Load Fee
-
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
2.51%
Expense Ratio
2.94%
Top Fund Holdings
Name Position Value % of Fund
Evogene Ltd 51.10 k 1.97 m 9.55
Pluristem Therapeutics Inc 183.70 k 1.94 m 9.37
Kamada Ltd 99.55 k 1.75 m 8.47
Mazor Robotics Ltd 66.00 k 1.68 m 8.14
Compugen Ltd 65.13 k 1.65 m 7.98
Clal Biotechnology Industries 320.00 k 1.57 m 7.60
OPKO Health Inc 26.00 k 1.43 m 6.93
Protalix BioTherapeutics Inc 147.00 k 1.24 m 5.98
Redhill Biopharma Ltd 170.00 k 957.95 k 4.63
Brainsway Ltd 29.00 k 941.92 k 4.56
Profile
Harel 4B Selected Biomed is an open-end fund registered in Israel. The objective of the fund is to exceed to TA Biomed Index. The fund primarly invests in Biotechnology and Pharmaceutical equities.
ADDRESS
Ilanot Fund Management
PHONE
-
WEBSITE
-